Prospective Quality Improvement Project for High-Risk Diabetes Patients

Launched by TAIPEI MEDICAL UNIVERSITY WANFANG HOSPITAL · Jun 24, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at ways to improve the health and quality of life for people with diabetes who may also have a hidden infection called latent tuberculosis (TB). In Taiwan, many people with TB also have diabetes, which can make their treatment more complicated. The goal of the study is to encourage diabetic patients to get tested and treated for this latent TB infection, as it is an important health issue.

To be part of this trial, participants need to be at least 20 years old and have a history of poorly controlled diabetes, shown by a blood test result called HbA1C of more than 9% in the past year. Unfortunately, those who are very young or unable to answer questions about their health cannot take part. If eligible, participants can expect to receive support and resources that will help them manage both their diabetes and any potential TB infection, contributing to their overall health and well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diabetic patients had a record of glycated hemoglobin (HbA1C%) greater than 9% in the past year.
• Exclusion Criteria:
• • Be younger than 20 years old.
• • Unconsciousness or severe dementia, unable to conduct quality of life questionnaire assessment.